Jaguar Health Inc. implemented a 1-for-15 reverse split of its issued and outstanding common stock.
The company's common shares began trading on a split-adjusted basis at market open June 1.
Jaguar Health also reduced its authorized shares to 210 million, consisting of 150 million common shares, 50 million non-voting common stock and 10 million blank check preferred stock.
Computershare Trust Co. NA acted as exchange agent for the reverse stock split.
San Francisco-based Jaguar Health is a commercial stage natural products pharmaceuticals company that develops novel, sustainably derived gastrointestinal products.
